On 18 October, Cancer Society Auckland Northland (CSAN) hosted a Circle of Hope function for people who are leaving gifts in their wills to the Society. The function included a tour of the Auckland Cancer Society Research Centre (ACSRC) at the University of Auckland to show these generous supporters how their bequests will help the ACSRC continue their vital research. ACSRC Director Distinguished Professor Bill Denny welcomed guests and spoke about past advancements in cancer research and hopes for the future.
Money that people leave in their wills is the largest single source of income for CSAN. Everyone who plans to leave a gift in their will is invited to be part of the Circle of Hope, a group established in 2012 to acknowledge and thank these special donors for supporting CSAN’s work in the future.
The October Circle of Hope event was a fascinating insight into how advances in cancer research mean people are living better and longer with cancer. ACSRC Director Distinguished Professor Bill Denny spoke about the remarkable progress that has been achieved over the past 40 years and predicted the focus of future research in his speech “Chemotherapy, Immunotherapy and Beyond”.
The event was a huge success largely thanks to the support of the ACSRC, with about two dozen staff volunteering to guide guests on a behind-the-scenes tour of the research laboratories.
The day concluded with a Devonshire tea where guests enjoyed the opportunity to talk informally with CSAN and ACSRC staff. The feedback from guests was very positive, with many stating how impressed they were by the ground-breaking research being done here in Auckland.
Each year CSAN contributes over $2 million towards the work of the ACSRC and funds many research projects at the University of Auckland. It is New Zealand's largest private funder of cancer research.
We are proud to work in close partnership with the Society and immensely grateful for its tremendous support. We thank the Cancer Society Auckland Northland and all its generous donors for their commitment to cancer research.